Morgan Stanley
ETTX

Morgan Stanley’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Morgan Stanley’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed – – 8238
2022
Q1 		$0 Buy
16
+15
+1,500% +$27 ﹤0.01% 8310
2021
Q4 		$0 Buy
+1
New +$3 ﹤0.01% 8313
2020
Q3 		– Sell
-84
Closed – – 6901
2020
Q2 		$0 Buy
+84
New +$230 ﹤0.01% 6802
2019
Q1 		– Sell
-68
Closed – – 6776
2018
Q4 		$0 Buy
+68
New +$448 ﹤0.01% 6807

Other funds holding ETTX

GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley's ETTX Position: Q2 2022 in Review

Morgan Stanley sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2022, closing a stake of 16 shares.

Morgan Stanley first reported a position in ETTX in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q1 2022. 27 funds tracked by Wall St. Rank hold ETTX as of Q2 2022.

  • Morgan Stanley reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 16 Entasis Therapeutics Holdings Inc. shares in Q2 2022.
  • Morgan Stanley first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2018 and held it in 4 quarters.
  • Morgan Stanley's Entasis Therapeutics Holdings Inc. position peaked at $0 in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.